Ready to stop using meth?

ABOUT PARTICIPATION IN OUTLAST

Before participating in OUTLAST, you will be screened through a series of steps, to see if you qualify. If you are eligible, you will begin to receive the study drug. The study drug will be administered through an IV line over 30 minutes. You will receive 6 doses of either IXT-m200 or placebo, spaced 4 weeks apart. You will be randomly assigned, like by the flip of a coin, to either IXT-m200 or placebo. The group of patients assigned to IXT-m200 will be compared to the group of patients assigned to placebo to help researchers better understand the effects of IXT-m200. The study team will follow all patients closely throughout study participation. All participants will follow the same visit schedule and will be asked to complete the same study procedures.

​

As part of the study, you will be asked to record your drug use daily in a smartphone app. You will also use the app to record your saliva drug tests. Remember, your study participation is confidential, and data collected during the study will not be reported to any law enforcement agency. You will also use the app to connect with your recovery coach. Your recovery coach has been where you are today. They are in long-term recovery from their own drug use and know what you are going through. Your recovery coach will be available for a phone and/or video call once per week for the first 3 months and beyond. In addition to the scheduled calls, your recovery coach will be available by text during working hours.